nodes	percent_of_prediction	percent_of_DWPC	metapath
Adenosine—Electrocardiogram ST segment depression—Varenicline—nicotine dependence	0.1	0.144	CcSEcCtD
Adenosine—Coronary artery disease—Varenicline—nicotine dependence	0.0575	0.0828	CcSEcCtD
Adenosine—ADA—cardiovascular system—nicotine dependence	0.0337	0.122	CbGeAlD
Adenosine—ADORA2A—cardiovascular system—nicotine dependence	0.0307	0.111	CbGeAlD
Adenosine—Scotoma—Varenicline—nicotine dependence	0.0299	0.0431	CcSEcCtD
Adenosine—ADK—cardiovascular system—nicotine dependence	0.0276	0.0996	CbGeAlD
Adenosine—DPP4—cardiovascular system—nicotine dependence	0.0267	0.0965	CbGeAlD
Adenosine—ADORA1—cardiovascular system—nicotine dependence	0.0265	0.0957	CbGeAlD
Adenosine—Chest discomfort—Varenicline—nicotine dependence	0.0257	0.037	CcSEcCtD
Adenosine—Ventricular extrasystoles—Varenicline—nicotine dependence	0.0252	0.0362	CcSEcCtD
Adenosine—Blood pressure increased—Varenicline—nicotine dependence	0.0227	0.0327	CcSEcCtD
Adenosine—ADK—midbrain—nicotine dependence	0.0215	0.0778	CbGeAlD
Adenosine—ADORA1—midbrain—nicotine dependence	0.0207	0.0748	CbGeAlD
Adenosine—ADORA2B—brain—nicotine dependence	0.0181	0.0654	CbGeAlD
Adenosine—Atrial fibrillation—Varenicline—nicotine dependence	0.0174	0.0251	CcSEcCtD
Adenosine—Cerebrovascular accident—Varenicline—nicotine dependence	0.0168	0.0242	CcSEcCtD
Adenosine—ADA—brain—nicotine dependence	0.0166	0.0598	CbGeAlD
Adenosine—Affect lability—Varenicline—nicotine dependence	0.0162	0.0234	CcSEcCtD
Adenosine—Mood swings—Varenicline—nicotine dependence	0.0156	0.0225	CcSEcCtD
Adenosine—ADORA2A—brain—nicotine dependence	0.0151	0.0544	CbGeAlD
Adenosine—Abdominal discomfort—Varenicline—nicotine dependence	0.0137	0.0197	CcSEcCtD
Adenosine—ADK—brain—nicotine dependence	0.0135	0.0489	CbGeAlD
Adenosine—Pollakiuria—Varenicline—nicotine dependence	0.0132	0.019	CcSEcCtD
Adenosine—DPP4—brain—nicotine dependence	0.0131	0.0474	CbGeAlD
Adenosine—ADORA1—brain—nicotine dependence	0.013	0.047	CbGeAlD
Adenosine—Acute coronary syndrome—Varenicline—nicotine dependence	0.0125	0.018	CcSEcCtD
Adenosine—Myocardial infarction—Varenicline—nicotine dependence	0.0125	0.0179	CcSEcCtD
Adenosine—Bradycardia—Varenicline—nicotine dependence	0.0116	0.0167	CcSEcCtD
Adenosine—Hypoaesthesia—Varenicline—nicotine dependence	0.0114	0.0163	CcSEcCtD
Adenosine—Tinnitus—Varenicline—nicotine dependence	0.0106	0.0153	CcSEcCtD
Adenosine—Cardiac disorder—Varenicline—nicotine dependence	0.0106	0.0152	CcSEcCtD
Adenosine—Mediastinal disorder—Varenicline—nicotine dependence	0.0103	0.0148	CcSEcCtD
Adenosine—Arrhythmia—Varenicline—nicotine dependence	0.0102	0.0147	CcSEcCtD
Adenosine—Dysgeusia—Varenicline—nicotine dependence	0.00973	0.014	CcSEcCtD
Adenosine—Back pain—Varenicline—nicotine dependence	0.00961	0.0138	CcSEcCtD
Adenosine—Vision blurred—Varenicline—nicotine dependence	0.00936	0.0135	CcSEcCtD
Adenosine—Tremor—Varenicline—nicotine dependence	0.00931	0.0134	CcSEcCtD
Adenosine—Agitation—Varenicline—nicotine dependence	0.00913	0.0131	CcSEcCtD
Adenosine—Angioedema—Varenicline—nicotine dependence	0.00908	0.0131	CcSEcCtD
Adenosine—Syncope—Varenicline—nicotine dependence	0.00891	0.0128	CcSEcCtD
Adenosine—Palpitations—Varenicline—nicotine dependence	0.00878	0.0126	CcSEcCtD
Adenosine—Loss of consciousness—Varenicline—nicotine dependence	0.00873	0.0126	CcSEcCtD
Adenosine—Cough—Varenicline—nicotine dependence	0.00867	0.0125	CcSEcCtD
Adenosine—Convulsion—Varenicline—nicotine dependence	0.00861	0.0124	CcSEcCtD
Adenosine—Hypertension—Varenicline—nicotine dependence	0.00858	0.0123	CcSEcCtD
Adenosine—Chest pain—Varenicline—nicotine dependence	0.00846	0.0122	CcSEcCtD
Adenosine—Anxiety—Varenicline—nicotine dependence	0.00843	0.0121	CcSEcCtD
Adenosine—Discomfort—Varenicline—nicotine dependence	0.00836	0.012	CcSEcCtD
Adenosine—Dry mouth—Varenicline—nicotine dependence	0.00827	0.0119	CcSEcCtD
Adenosine—Shock—Varenicline—nicotine dependence	0.00798	0.0115	CcSEcCtD
Adenosine—Tachycardia—Varenicline—nicotine dependence	0.00791	0.0114	CcSEcCtD
Adenosine—Hyperhidrosis—Varenicline—nicotine dependence	0.00784	0.0113	CcSEcCtD
Adenosine—Hypotension—Varenicline—nicotine dependence	0.00758	0.0109	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.00739	0.0106	CcSEcCtD
Adenosine—Dyspnoea—Varenicline—nicotine dependence	0.00723	0.0104	CcSEcCtD
Adenosine—Somnolence—Varenicline—nicotine dependence	0.00721	0.0104	CcSEcCtD
Adenosine—Pain—Varenicline—nicotine dependence	0.00693	0.00998	CcSEcCtD
Adenosine—Urticaria—Varenicline—nicotine dependence	0.00644	0.00927	CcSEcCtD
Adenosine—Hypersensitivity—Varenicline—nicotine dependence	0.00597	0.0086	CcSEcCtD
Adenosine—Asthenia—Varenicline—nicotine dependence	0.00582	0.00837	CcSEcCtD
Adenosine—Dizziness—Varenicline—nicotine dependence	0.00536	0.00772	CcSEcCtD
Adenosine—Vomiting—Varenicline—nicotine dependence	0.00516	0.00742	CcSEcCtD
Adenosine—Rash—Varenicline—nicotine dependence	0.00511	0.00736	CcSEcCtD
Adenosine—Dermatitis—Varenicline—nicotine dependence	0.00511	0.00735	CcSEcCtD
Adenosine—Headache—Varenicline—nicotine dependence	0.00508	0.00731	CcSEcCtD
Adenosine—Nausea—Varenicline—nicotine dependence	0.00482	0.00693	CcSEcCtD
Adenosine—ADORA1—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.00144	0.0508	CbGpPWpGaD
Adenosine—ADORA2B—GPCR ligand binding—TAS2R16—nicotine dependence	0.00102	0.0361	CbGpPWpGaD
Adenosine—ADA—Circadian rythm related genes—CHRNB2—nicotine dependence	0.000903	0.0319	CbGpPWpGaD
Adenosine—ADORA1—GPCR ligand binding—TAS2R16—nicotine dependence	0.000871	0.0307	CbGpPWpGaD
Adenosine—SLC28A3—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000859	0.0303	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—FGD1—nicotine dependence	0.000745	0.0263	CbGpPWpGaD
Adenosine—ADORA2A—GPCR ligand binding—TAS2R16—nicotine dependence	0.000672	0.0237	CbGpPWpGaD
Adenosine—ADORA1—Circadian rythm related genes—CHRNB2—nicotine dependence	0.000672	0.0237	CbGpPWpGaD
Adenosine—ADA—Circadian rythm related genes—DRD2—nicotine dependence	0.000668	0.0236	CbGpPWpGaD
Adenosine—ADORA2B—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000662	0.0234	CbGpPWpGaD
Adenosine—ADORA1—G alpha (i) signalling events—OPRM1—nicotine dependence	0.000606	0.0214	CbGpPWpGaD
Adenosine—ADORA2B—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000579	0.0204	CbGpPWpGaD
Adenosine—ADORA2B—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000567	0.02	CbGpPWpGaD
Adenosine—ADORA1—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000563	0.0199	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—TAS2R16—nicotine dependence	0.000525	0.0185	CbGpPWpGaD
Adenosine—ADORA2A—Circadian rythm related genes—CHRNB2—nicotine dependence	0.000519	0.0183	CbGpPWpGaD
Adenosine—ADORA1—Circadian rythm related genes—DRD2—nicotine dependence	0.000497	0.0175	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000492	0.0174	CbGpPWpGaD
Adenosine—ADORA1—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000482	0.017	CbGpPWpGaD
Adenosine—ADORA2B—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000478	0.0169	CbGpPWpGaD
Adenosine—ADORA2B—GPCR downstream signaling—FGD1—nicotine dependence	0.000454	0.016	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—TAS2R16—nicotine dependence	0.000447	0.0158	CbGpPWpGaD
Adenosine—ADORA1—G alpha (i) signalling events—DRD2—nicotine dependence	0.000438	0.0155	CbGpPWpGaD
Adenosine—ADORA2A—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000434	0.0153	CbGpPWpGaD
Adenosine—ADORA2B—GPCR ligand binding—OPRM1—nicotine dependence	0.000432	0.0152	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—FGD1—nicotine dependence	0.000412	0.0146	CbGpPWpGaD
Adenosine—ADORA2B—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00041	0.0145	CbGpPWpGaD
Adenosine—ADORA1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000407	0.0144	CbGpPWpGaD
Adenosine—ADK—Metabolism—CYP2A7—nicotine dependence	0.000402	0.0142	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—FGD1—nicotine dependence	0.000386	0.0136	CbGpPWpGaD
Adenosine—ADORA2A—Circadian rythm related genes—DRD2—nicotine dependence	0.000383	0.0135	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00038	0.0134	CbGpPWpGaD
Adenosine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000372	0.0131	CbGpPWpGaD
Adenosine—ADORA1—GPCR ligand binding—OPRM1—nicotine dependence	0.000367	0.013	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—FGD1—nicotine dependence	0.000351	0.0124	CbGpPWpGaD
Adenosine—ADORA1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000348	0.0123	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—TAS2R16—nicotine dependence	0.000345	0.0122	CbGpPWpGaD
Adenosine—ADORA2A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000314	0.0111	CbGpPWpGaD
Adenosine—ADORA2B—GPCR ligand binding—DRD2—nicotine dependence	0.000312	0.011	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—TAS2R16—nicotine dependence	0.00031	0.011	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—FGD1—nicotine dependence	0.000298	0.0105	CbGpPWpGaD
Adenosine—ADORA2A—GPCR ligand binding—OPRM1—nicotine dependence	0.000283	0.01	CbGpPWpGaD
Adenosine—ADA—Metabolism—CYP2A7—nicotine dependence	0.000273	0.00965	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—FGD1—nicotine dependence	0.000271	0.00955	CbGpPWpGaD
Adenosine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000269	0.0095	CbGpPWpGaD
Adenosine—ADORA1—GPCR ligand binding—DRD2—nicotine dependence	0.000265	0.00937	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—TAS2R16—nicotine dependence	0.000264	0.00932	CbGpPWpGaD
Adenosine—ADORA2B—GPCR downstream signaling—OPRM1—nicotine dependence	0.000244	0.00861	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—FGD1—nicotine dependence	0.000244	0.0086	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—OPRM1—nicotine dependence	0.000222	0.00782	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—AKR1B10—nicotine dependence	0.000215	0.00759	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—OPRM1—nicotine dependence	0.000207	0.00732	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—FGD1—nicotine dependence	0.000207	0.00731	CbGpPWpGaD
Adenosine—ADORA2A—GPCR ligand binding—DRD2—nicotine dependence	0.000205	0.00723	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—TAS2R16—nicotine dependence	0.000204	0.00719	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—OPRM1—nicotine dependence	0.000188	0.00665	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—AKR1B10—nicotine dependence	0.000183	0.00646	CbGpPWpGaD
Adenosine—ADORA2B—GPCR downstream signaling—DRD2—nicotine dependence	0.000176	0.00622	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—DRD2—nicotine dependence	0.00016	0.00565	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—OPRM1—nicotine dependence	0.00016	0.00565	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—FGD1—nicotine dependence	0.00016	0.00564	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—WASF2—nicotine dependence	0.000152	0.00535	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—DRD2—nicotine dependence	0.00015	0.00529	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—OPRM1—nicotine dependence	0.000145	0.00513	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—WASF1—nicotine dependence	0.000145	0.00513	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—AKR1B10—nicotine dependence	0.000141	0.00499	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—DRD2—nicotine dependence	0.000136	0.00481	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—OPRM1—nicotine dependence	0.000131	0.00462	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—WASF2—nicotine dependence	0.000129	0.00455	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—WASF1—nicotine dependence	0.000124	0.00436	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—DRD2—nicotine dependence	0.000116	0.00409	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—OPRM1—nicotine dependence	0.000111	0.00393	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—DRD2—nicotine dependence	0.000105	0.00371	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—WASF2—nicotine dependence	9.95e-05	0.00351	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—WASF1—nicotine dependence	9.54e-05	0.00337	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—DRD2—nicotine dependence	9.46e-05	0.00334	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—OPRM1—nicotine dependence	8.59e-05	0.00303	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—DRD2—nicotine dependence	8.04e-05	0.00284	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—DRD2—nicotine dependence	6.21e-05	0.00219	CbGpPWpGaD
